MedPath

Vall d'Hebron Research Institute

Vall d'Hebron Research Institute logo
🇪🇸Spain
Ownership
Private
Established
1994-01-01
Employees
1K
Market Cap
-
Website
http://www.vhir.org

Clinical Trials

247

Active:7
Completed:125

Trial Phases

5 Phases

Phase 1:2
Phase 2:10
Phase 3:13
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (174 trials with phase data)• Click on a phase to view related trials

Not Applicable
121 (69.5%)
Phase 4
28 (16.1%)
Phase 3
13 (7.5%)
Phase 2
10 (5.7%)
Phase 1
2 (1.1%)

A Novel Psychological Intervention for Adults With Bipolar Disorder and Attention Deficit Hyperactivity Disorder Comorbidity (VECTOR)

Not Applicable
Not yet recruiting
Conditions
ADHD
BD
First Posted Date
2025-06-26
Last Posted Date
2025-06-26
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
68
Registration Number
NCT07039903
Locations
🇪🇸

Hospital Clínic de Barcelona and Vall d'Hebron University Hospital, Barcelona, Spain

PPI Refractory - GERD Mechanisms in Systemic Sclerosis

Not yet recruiting
Conditions
Systemic Sclerosis (SSc)
GERD (Gastroesophageal Reflux Disease)
First Posted Date
2025-06-15
Last Posted Date
2025-06-15
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
147
Registration Number
NCT07022912

Treatment of Rumination

Not Applicable
Recruiting
Conditions
Rumination Syndrome
First Posted Date
2025-05-14
Last Posted Date
2025-07-09
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
40
Registration Number
NCT06971354
Locations
🇪🇸

Vall d'Hebron Research Institute, Barcelona, Spain

tDCS in Adults With ASD and/or ADHD Without Intellectual Disability

Not Applicable
Completed
Conditions
Autism Spectrum Disorder
Attention Deficit Disorder With Hyperactivity
First Posted Date
2025-04-27
Last Posted Date
2025-08-01
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
25
Registration Number
NCT06946433
Locations
🇪🇸

Hospital Universitari Vall d'Hebron, Barcelona, Spain

Spanish Natural History Study for LAMA2 Muscular Dystrophy

Recruiting
Conditions
LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)
Merosin Deficient CMD (Full or Partial)
Merosin Deficient Congenital Muscular Dystrophy
Muscular Dystrophies
Cohort Studies
First Posted Date
2025-04-11
Last Posted Date
2025-04-11
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
100
Registration Number
NCT06924125
Locations
🇪🇸

University Hospital Vall d'Hebron, Barcelona, Spain

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 50
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.